Higher levels of CCL18 in IPF patients than controls. Discriminatory ability of levels higher than 38.7 ng/mL: sensitivity 66.2% and specificity 67.4%No prediction of 5-year mortality. Here, CCL18 is linked to idiopathic pulmonary fibrosis.